Boolean analysis identifies CD38 as a biomarker of aggressive localized prostate cancer

The introduction of serum Prostate Specific Antigen (PSA) testing nearly 30 years ago has been associated with a significant shift towards localized disease and decreased deaths due to prostate cancer. Recognition that PSA testing has caused over diagnosis and over treatment of prostate cancer has g...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Sahoo, Debashis, Wei, Wei, Auman, Heidi, Hurtado-Coll, Antonio, Carroll, Peter R., Fazli, Ladan, Gleave, Martin E., Lin, Daniel W., Nelson, Peter S., Simko, Jeff, Thompson, Ian M., Leach, Robin J., Troyer, Dean A., True, Lawrence D., McKenney, Jesse K., Feng, Ziding, Brooks, James D.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5814231/
https://ncbi.nlm.nih.gov/pubmed/29464091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23973
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados